The ALS Therapy Alliance is designated by the IRS as a not-for-profit 501 (c) (3) organization.
Our Breakthrough ALS annual fundraising campaign (formerly known as Researching a Cure) is now entering its 13th year with successful fundraising partners such as CVS/pharmacy and their Advancing Medical Research program.
A decade's worth of great strides has been made in leading-edge research to find a cure for this devastating and fatal disease known as amyotrophic lateral sclerosis (ALS) or Lou Gehrig's Disease.
To date, there is no known cure and the cause is unknown, but there is much hope that one will be found.
Our scientists, researchers, clinicians and doctors from around the world have worked tirelessly along side others from The Northeast ALS Consortium (NEALS), Project A.L.S., The Angel Fund and The ALS Association (ALSA) running diagnostic tests, conducting clinical trails and pushing research forward.
The ALS Therapy Alliance's partners have been pivotal in providing additional research and insight into potential treatments for ALS and other related diseases.
These co-sponsored projects have been made possible due to funds raised through our annual Breakthrough ALS fundraising campaign with CVS/pharmacy.
Currently, CVS/pharmacy is the largest corporate donor to the ALS Therapy Alliance. By asking its customers to donate to the cause for the last nine years, CVS/pharmacy and its team have helped raise more than $30 million for the ALS Therapy Alliance and its participating members.